Table 6.
C57BL/6J | NJ L-Fabp−/− | WU L-Fabp−/− | |
---|---|---|---|
Females | |||
n | 10 | 6 | 10 |
Final BW, g | 25.3 ± 1.2a | 24.6 ± 1.1a | 21.2 ± 0.6b |
Weight gain, g | 7.0 ± 1.0a | 6.1 ± 1.0a | 3.2 ± 0.3b |
Liver, g | 1.1 ± 0.1 | 1.0 ± 0.03 | 0.9 ± 0.1 |
Liver/body, % | 4.3 ± 0.2 | 4.0 ± 0.2 | 4.3 ± 0.2 |
Fat, g | 0.8 ± 0.1a | 0.6 ± 0.1a | 0.3 ± 0.02b |
Fat/body, % | 2.8 ± 0.4a | 2.4 ± 0.2a | 1.3 ± 0.1b |
Serum | |||
TG, mg/dl | 12.9 ± 2.9 | 18.5 ± 3.4 | 21.2 ± 5.4 |
Chol, mg/dl | 69.4 ± 3.4 | 56.8 ± 4.7 | 56.5 ± 4.9 |
FFA, mmol/l | 0.32 ± 0.05a | 0.64 ± 0.1b | 0.50 ± 0.06a |
Glucose, mg/dl | 337 ± 27a | 241 ± 30b | 251 ± 29a |
Hepatic lipid | |||
TG, μg/mg | 302 ± 23a | 361 ± 28a | 152 ± 28b |
Chol, μg/mg | 20.8 ± 1.7a | 18.4 ± 1.3a | 12.3 ± 3.5b |
FFA, nmol/mg | 80 ± 7 | 67 ± 5 | 60 ± 4 |
Males | |||
n | 9 | 11 | 6 |
Final BW, g | 32.9 ± 0.8a | 36.0 ± 1.0b | 32.8 ± 1.6a |
Weight gain, g | 9.8 ± 0.6a | 12.5 ± 0.6b | 10.3 ± 1.5a |
Liver, g | 1.2 ± 0.04 | 1.3 ± 0.1 | 1.3 ± 0.1 |
Liver/body, % | 3.7 ± 0.1 | 3.5 ± 0.2 | 3.8 ± 0.1 |
Fat, g | 1.4 ± 0.1 | 1.3 ± 0.1 | 1.5 ± 0.2 |
Fat/body, % | 4.3 ± 0.2a | 3.8 ± 0.1a,b | 4.5 ± 0.4a |
Serum | |||
TG, mg/dl | 28.3 ± 2.9 | 23.2 ± 3.1 | 37.5 ± 6.5 |
Chol, mg/dl | 106.8 ± 4.9 | 90.7 ± 9.5 | 105.7 ± 8.9 |
FFA, mmol/l | 0.30 ± 0.3a | 0.49 ± 0.09a,b | 0.54 ± 0.06b |
Glucose, mg/dl | 349 ± 12a | 239 ± 35b | 434 ± 41a |
Hepatic lipid | |||
TG, μg/mg | 272 ± 48a | 274 ± 50a | 131 ± 32b |
Chol, μg/mg | 18.0 ± 1.3 | 19.2 ± 1.4 | 17.2 ± 0.8 |
FFA, nmol/mg | 98 ± 8 | 87 ± 4 | 96 ± 4 |
Values are means ± SE; n, no. of mice. a,bDifferent superscript letters indicate significant differences between genotypes: P < 0.05. Hepatic lipid was assayed in 5–7 animals per genotype. Serum was assayed in 5–6 animals per genotype.